Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Catherine D. Hughes"'
Autor:
Catherine D. Hughes, David L. Scott, Fowzia Ibrahim, on behalf of TITRATE Programme Investigators
Publikováno v:
BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-14 (2018)
Abstract Background We systematically reviewed the effectiveness of intensive treatment strategies in achieving remission in patients with both early and established Rheumatoid Arthritis (RA). Methods A systematic literature review and meta-analysis
Externí odkaz:
https://doaj.org/article/bb5b3d9b403a4123be5d67e047fe1bdf
Autor:
René E M Toes, Bruce W Kirkham, L A Trouw, Michelle D van den Beukel, Leonie S Taams, Catherine D Hughes, Sarah E Ryan, Kathryn J A Steel, Karin A J van Schie, Bina Menon
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objective Undifferentiated, early inflammatory arthritis (EIA) can differentiate into seropositive or seronegative rheumatoid arthritis (RA), peripheral spondyloarthritis (SpA) or remain as seronegative undifferentiated inflammatory arthritis (UIA).
Externí odkaz:
https://doaj.org/article/1632d54ad26941bea5e5f23ce49f79fa
Autor:
Catherine D. Hughes, Joseph Nathan, Libin Mathew, Andrew E. Pink, Richard T. Woolf, Catherine Smith, Bina Menon, Bruce Kirkham
Publikováno v:
Arthritis & Rheumatology.
Autor:
Shirish R. Sangle, Catherine D. Hughes, Lucinda Barry, Sumera Qureshi, Chee Ken Cheah, Yih Jia Poh, David P. D'Cruz
Publikováno v:
Autoimmunity Reviews. 22:103352
Autor:
Leonie S. Taams, Sarah Ryan, Catherine D Hughes, Bruce Kirkham, Bina Menon, Sylvine Lahnunlimi, Kathryn J. A. Steel
Publikováno v:
Rheumatology. 59
Background Early inflammatory arthritis (EIA) is classically described as arthritis of ≤ 12 months duration. EIA can be sub-divided into psoriatic arthritis (PsA), other spondyloarthritides (SpA), rheumatoid arthritis (RA) or reactive arthritis (Re
Autor:
Zena Willsmore, Bina Menon, Catherine H. Smith, R T Woolf, Andrew Pink, Catherine D Hughes, Bruce Kirkham
Publikováno v:
Rheumatology. 59
Background Dupilumab is a recombinant human monoclonal antibody that inhibits signalling of interleukin-4 and interleukin-13. It has NICE approval for use in patients with moderate to severe atopic eczema who have failed at least one standard therapy
Publikováno v:
Journal of rheumatology. Supplement, Vol. 96 (2020) pp. 4-10
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) held a trainees symposium at its 2019 annual meeting in Paris, France. Rheumatology and dermatology trainees engaged in psoriasis or psoriatic arthritis research pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b6d17c0e2fc05b966a58f4356b15aa
https://archive-ouverte.unige.ch/unige:156452
https://archive-ouverte.unige.ch/unige:156452
Publikováno v:
Rheumatology. 58
Autor:
Catherine H. Smith, Bina Menon, L. B. Kirkham, Z. Willsmore, R. Woolf, Catherine D Hughes, Andrew Pink
Publikováno v:
Annals of the Rheumatic Diseases. 79:1136.1-1136
Background:Enthesitis is a key feature of peripheral Spondyloarthritis (SpA). Several pro-inflammatory cytokines including Interleukin-17 and Interleukin-23 are found within the enthesis (1). Dupilumab is a recombinant human monoclonal antibody that
Publikováno v:
Rheumatology. 57